April 19 was elected to the Panel of Directors effective, 2011. Dr. Jensen offers a lot more than 24 years of global drug development experience in both pharmaceutical and biotechnology businesses, across therapeutic areas including neurology, cardiovascular, anti-infective, oncology and immunology. Most recently, he served as Corporate Senior Vice President, and General Manager, R&D for Japan and Asia/Pacific at Schering-Plough Corporation. Wise Little, Ph.D., M.D., resigned from the Table of Directors effective April 19, 2011. Dr. Little served on Acorda’s Plank of Directors since the Company’s founding in 1995, and will continue to advise the Company in a consulting role as Special Scientific Advisor..Anthurium will discuss its ‘Community Collaboration Centers for business’ platform.S. Workforce includes 78 million Boomers. Research implies that giving people flexible work schedules and mobility, and giving organizations usage of a skilled and vetted, on-demand workforce results in a win-win,’ said Simard. ‘The health care industry especially requirements innovative workforce solutions that enable pharmacists, nurses, doctors and other professionals to function collaboratively and engage individuals to meet the demand powered by chronic ailments and our aging population. Our ASA workshops highlight how our ‘work & people’ solutions support new settings of working.’ Maturing in America will be kept from March 28 to April 1 at the Marriott Wardman Park Resort in Washington, D.C..